Reverse-D-4F improves endothelial progenitor cell function and attenuates LPS-induced acute lung injury

Area of Science:

• Cardiovascular Biology
• Pulmonary Medicine
• Cellular Biology

Background:

• Acute lung injury (ALI) involves elevated pro-inflammatory mediators that impair endothelial progenitor cell (EPC) function.
• Enhancing EPC numbers and function is crucial for mitigating ALI progression.

Purpose of the Study:

• To investigate the therapeutic potential of high-density lipoprotein reverse-D-4F (Rev-D4F) in repairing lipopolysaccharide (LPS)-induced lung damage in a mouse model of ALI.
• To determine if Rev-D4F improves EPC numbers and function in LPS-induced ALI.

Main Methods:

• Lipopolysaccharide (LPS) induced ALI in mice, followed by Rev-D4F intraperitoneal injections.
• Assessed lung repair, EPC quantity and quality, and signaling pathways using immunohistochemistry, flow cytometry, MTT assays, transwell assays, and western blotting.

Main Results:

• Rev-D4F mitigated LPS-induced pulmonary edema and reduced pro-inflammatory mediators (TNF-α, ET-1).
• It inhibited inflammatory cell infiltration, reduced lung inflammation, and repaired pulmonary capillary endothelial cells.
• Rev-D4F boosted circulating EPC numbers, enhanced EPC differentiation, and restored LPS-impaired EPC function via the PI3K/AKT/eNOS pathway.

Conclusions:

• Rev-D4F demonstrates a significant vasculoprotective effect in ALI by enhancing EPC numbers and function.
• Rev-D4F reverses LPS-induced EPC dysfunction, partly mediated by the PI3K/AKT/eNOS signaling pathway.